Obenow 10 Tablet 10 is used to manage primary biliary cholangitis (PBC), a chronic autoimmune disease affecting the liver's bile ducts. It belongs to a class of medicines known as farnesoid X receptor (FXR) agonists.
In addition to its primary use, this medicine can be prescribed either in combination with ursodeoxycholic acid (UDCA) for patients who have an inadequate response to UDCA alone or as a standalone treatment for those who cannot tolerate UDCA. PBC causes progressive destruction of bile ducts, leading to bile accumulation, inflammation, and scarring of the liver tissue.
Your doctor will determine the appropriate dosage and frequency based on your specific condition. Before starting this medicine, inform your doctor about any pre-existing health conditions or ongoing medications you might be taking. Should you experience any side effects while using this medicine, notify your doctor promptly. Continue taking the medicine for the entire duration prescribed by your doctor for optimal results.